Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0.035 mg, 28-count tablets per...

FDA Recall #D-015-2013 — Class II — October 19, 2012

Recall #D-015-2013 Date: October 19, 2012 Classification: Class II Status: Terminated

Product Description

Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0.035 mg, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA; NDC 52544-953-28.

Reason for Recall

Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).

Recalling Firm

Watson Laboratories Inc — Corona, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

12,333 cartons

Distribution

Nationwide and Puerto Rico

Code Information

Lot #: 514767AA, Exp 03/31/14

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated